Totally implanted central venous access devices inserted by the femoral route: A narrative review and the proposal of a novel approach, the FICC-port

Author:

Annetta Maria Giuseppina1ORCID,Marche Bruno2,Ortiz Miluy Gloria3,Pittiruti Mauro4ORCID

Affiliation:

1. Department of Anesthesia and Intensive Care, Policlinico Universitario “A.Gemelli,” Rome, Lazio, Italy

2. Department of Hematology, Policlinico Universitario “A.Gemelli,” Rome, Lazio, Italy

3. Izasa Medical, Barcelona, Spain

4. Department of Surgery, Policlinico Universitario “A.Gemelli,” Rome, Lazio, Italy

Abstract

Background: Femoral ports are used in patients with indication to a totally implanted venous access device but with contraindication to chest-ports and brachial ports because of obstruction of the superior vena cava. In the last three decades, femoral ports have been implanted almost exclusively by cannulation of the common femoral vein at the groin, while the position of the tip has been assessed by X-ray. Methods: We report our experience with a new approach to femoral ports, which includes recent methods and techniques developed in the last few years. These novel femoral ports, which we call “FICC-ports,” are characterized by (a) long femoral 5 Fr polyurethane catheter inserted by ultrasound-guided puncture of the superficial femoral vein at mid-thigh; (b) intraprocedural location of the tip in the sub-diaphragmatic inferior vena cava, using ultrasound visualization by the transhepatic and/or the subcostal view; (c) low-profile or very low-profile reservoir implanted above the quadriceps muscle, at mid-thigh. Results: In the last 3 years, we have implanted 47 FICC-ports in young adults with mediastinal lymphoma compressing the superior vena cava. We had no immediate/early complication, and only three late complications (one kinking of the catheter in the subcutaneous tissue; one tip migration with secondary venous thrombosis; one persistent withdrawal occlusion due to fibroblastic sleeve). Conclusion: If there is indication to a femoral port, the implantation of a “FICC-port”—as described above—is to be strongly considered in terms of safety, effectiveness, and cost-effectiveness: no immediate-early complications, minimal late complications, no X-ray exposure, low invasiveness, low cost.

Publisher

SAGE Publications

Reference35 articles.

1. Infusion Therapy Standards of Practice, 8th Edition

2. Pittiruti M, Scoppettuolo G. Raccomandazioni GAVeCeLT 2021 per la indicazione, l’impianto e la gestione dei dispositivi per accesso venoso, https://www.gavecelt.it/nuovo/sites/default/files/uploads/Raccomandazioni%20GAVeCeLT%202021%20-%20v.2.0.pdf (2021, accessed December 2023)

3. A multicenter retrospective study on 4480 implanted PICC-ports: A GAVeCeLT project

4. Long-term femoral vein central venous access in cancer patients

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3